Table 3.
Relative to normal range* | FF/VI 100/25 µg OD (N=201) |
FF/VI 200/25 µg OD (N=202) |
FP 500 µg BD (N=100) |
|
---|---|---|---|---|
Baseline | n | 166 | 169 | 94 |
n (%) | High | 12 (7) | 14 (8) | 7 (7) |
Normal | 150 (90) | 146 (86) | 85 (90) | |
Low | 4 (2) | 9 (5) | 2 (2) | |
Any visit post-baseline | n | 183 | 179 | 87 |
n (%) | High | 32 (17) | 31 (17) | 11 (13) |
Normal | 132 (72) | 138 (77) | 57 (66) | |
Low | 19 (10) | 10 (6) | 19 (22) | |
Change from baseline | n | 156 | 156 | 83 |
(any visit post-baseline) | To high | 25 (16) | 21 (13) | 8 (10) |
n (%) | To normal or NC | 119 (76) | 126 (81) | 58 (70) |
To low | 12 (8) | 9 (6) | 17 (20) |
*Normal range is 11–138 nmol/24 h.
BD, twice daily; FF, fluticasone furoate; FP, fluticasone propionate; NC, no change; OD, once daily; VI, vilanterol.